It could make a substantial difference in the number of lives saved.” Hayes had no family history of gastrointestinal disease, which is one of the reasons he ignored his symptoms for so long. In fact, when he walked into the hospital in November, he was in better shape than everyone in the waiting room, Robertson remembers. Since then, Hayes has lost 50 pounds and is struggling to regain a sense of normalcy through multiple rounds of chemotherapy. He’s fighting an uphill battle — a 2004 study published in the Journal of the National Cancer Institute estimated the five-year survival rate for stage IV colon cancer to be 8.1%, and an institute study of cancer data put the survival rate at 6%. “It hurts like hell,” Hayes says of his recovery. “I always thought of myself as a man’s man, but I just discovered what a wuss I am.” Wade Hayes performs at the Stars Go Blue For Colon Cancer benefit on March 6, 2012. Thankfully, Hayes is anything but alone in Nashville. Willie Nelson called from Hawaii to wish him well. Kix Brooks helped him connect with the best doctors in the city. Jay DeMarcus from Rascal Flatts arranged for a private room at Vanderbilt hospital. “That part of it has been really shocking for me. I had no idea how many people cared about me or even knew I existed.” Robertson says that’s the kind of person Hayes is — modest to a fault; an introvert who enjoys reading detective dramas and has no desire to just sit around.
Colon Cancer Screenings Work, Twin Studies Report
29 issue of the New England Journal of Medicine. Two other recommended screening methods, however, also greatly reduce colon cancer mortality, the researchers found. Flexible sigmoidoscopy provides a 40 percent lower risk of dying from colon cancer, while annual fecal blood testing offers a 32 percent reduced death risk. “The inclusion of all these tests in the guidelines of major organizations continues to make sense,” said Dr. Durado Brooks, director of prostate and colorectal cancers for the American Cancer Society. “Quite honestly, many patients don’t have access to colonoscopy or are not willing to undergo a screening colonoscopy. Many studies have shown that offering patients options will increase the likelihood that they will complete some form of screening, and that is what is most important.” The results come from a pair of studies testing the long-term health benefits of screening for colon cancer. The first study investigated the use of colonoscopy and flexible sigmoidoscopy among a group of almost 89,000 health professionals during a 20-year period. Colonoscopy uses a thin tube equipped with a camera to examine the entire length of the colon in a procedure for which patients are usually sedated. Flexible sigmoidoscopy is a similar procedure but with a shorter tube that examines less of the colon, so patients do not have to be sedated. The study found colonoscopy was more effective in preventing cancer throughout the entire colon, but that both procedures greatly reduced the overall risk of colon cancer death, said Dr. Andrew Chan, an assistant professor at the Massachusetts General Hospital Gastrointestinal Unit and the co-senior author of the report. “Colonoscopy was superior to flexible sigmoidoscopy in terms of reducing the risk of colon cancer throughout the colon,” Chan said. “But this study really does support the existing guidelines and recommendations for individuals to undergo screening with either colonoscopy or sigmoidoscopy. I think this study shows there’s a very real impact on the risk of developing cancer and dying of cancer.” The second study focused on the fecal occult blood test, which uses chemical agents to detect trace amounts of blood in a person’s stool. Researchers led by Dr.